Kevin Voth

Kevin Voth

Kevin Voth


Kevin is an articling student at Aitken Klee LLP. Kevin has been involved in several patent actions, and attended a three week trial in the Federal Court of Canada in Toronto involving paliperidone palmitate. In addition to conducting legal research and writing, Kevin is involved in many aspects of pharmaceutical patent litigation.

Kevin earned a Ph.D. in Biochemistry from the University of Saskatchewan, and was a Postdoctoral Researcher at the University of Saskatchewan. Kevin is deeply familiar with phage display, molecular biology, protein purification, crystallization and molecular structure determination.

Kevin was a Writing Leader with the Legal Writing Academy at the University of Ottawa.


  • Juris Doctor, University of Ottawa Common Law (2023)
  • Doctor of Philosophy (Biochemistry), University of Saskatchewan (2019)
  • Honours Bachelor of Science, Biochemistry, University of Winnipeg (2013)


  • Voth & Grishin et al. “Structual biology of the invasion arsenal of Gram-negative bacterial pathogens. (2022) FEBS 289(6) p. 1385 – 1427.
  • Voth & Vaughn et al. “An indispensable role for the MavE effector of legionella pneumophila in lysosomal evasion. (2021) mBio 12(1) p. 1 – 21.
  • Voth et al. “Structural and functional characterization of legionella pneumophila effector MavL” (2021) Biomolecules 11(12) p. 1 – 18.
  • Voth et al. “The structure of Legionalla effector protein LpnE provides insights into its interaction with Oculocerebrorenal syndrome of Lowe (OCRL) protein.” (2019) FEBS 286(4) p. 710 – 725.